Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,510 shares of Class A Common Stock at a price of $21.47 per share on June 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On June 11, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,510 shares of Class A Common Stock.
• The sale was executed at a price of $21.47 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted by Boughton on September 10, 2023.
• Following the transaction, Boughton directly owns 154,345 shares of Hims & Hers Health, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale by an executive under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading based on short term movements.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates